PMID- 11465238 OWN - NLM STAT- MEDLINE DCOM- 20010809 LR - 20191210 IS - 0003-4975 (Print) IS - 0003-4975 (Linking) VI - 72 IP - 1 DP - 2001 Jul TI - Evaluation of predictors of clinical outcome after partial left ventriculectomy. PG - 91-5 AB - BACKGROUND: Outcome after partial left ventriculectomy (PLV) is difficult to predict. Our goal was to determine if clinical measurements including exercise testing could predict outcome after PLV. METHODS: Sixteen patients with dilated cardiomyopathy had left ventricular ejection fraction, left ventricular end-diastolic diameter, amount of mitral regurgitation (MR), New York Heart Association (NYHA) functional class, and cardiopulmonary exercise testing measurements measured before PLV and 3 months after PLV. Eleven patients who remained stable after PLV (group 1) were compared with 5 patients who deteriorated after PLV (group 2). RESULTS: Similar significant improvements were seen in both groups 3 months post-PLV with respect to left ventricular ejection fraction (group 1: 0.136+/-0.037 to 0.212+/-0.046; group 2: 0.139+/-0.042 to 0.179+/-0.073) and left ventricular end-diastolic diameter (group 1: 8.5+/-0.7 to 7.0+/-0.6 cm; group 2: 7.6+/-0.6 to 6.5+/-0.6 cm). The MR grade (1.0+/-0.6 versus 2.5+/-0.6), NYHA functional class (1.5+/-0.31 versus 2.5+/-0.6), and peak oxygen consumption (17.8+/-1.1 versus 12.2+/-2.0) were significantly different in the two groups 3 months after PLV (p < 0.05, analysis of variance). CONCLUSIONS: Patients that do not show significant improvement in peak oxygen consumption, NYHA class and significant decrease in the amount of MR 3 months after PLV, compared with pre-PLV, are at increased risk of clinically deteriorating. FAU - Bhat, G AU - Bhat G AD - Department of Medicine, University of Louisville, Kentucky, USA. g0bhat01@gwise.louisville.edu FAU - Dowling, R D AU - Dowling RD LA - eng PT - Evaluation Study PT - Journal Article PL - Netherlands TA - Ann Thorac Surg JT - The Annals of thoracic surgery JID - 15030100R SB - IM MH - Adult MH - Aged MH - Cardiomyopathy, Dilated/mortality/physiopathology/*surgery MH - Exercise Test MH - Female MH - Heart Failure/mortality/physiopathology/*surgery MH - Heart Ventricles/surgery MH - Hemodynamics/physiology MH - Hospital Mortality MH - Humans MH - Male MH - Middle Aged MH - Oxygen Consumption/physiology MH - Postoperative Complications/mortality/physiopathology MH - Prognosis MH - Stroke Volume/physiology MH - Survival Rate MH - Ventricular Dysfunction, Left/mortality/physiopathology/*surgery MH - Ventricular Function, Left/physiology EDAT- 2001/07/24 10:00 MHDA- 2001/08/10 10:01 CRDT- 2001/07/24 10:00 PHST- 2001/07/24 10:00 [pubmed] PHST- 2001/08/10 10:01 [medline] PHST- 2001/07/24 10:00 [entrez] AID - S0003-4975(01)02746-1 [pii] AID - 10.1016/s0003-4975(01)02746-1 [doi] PST - ppublish SO - Ann Thorac Surg. 2001 Jul;72(1):91-5. doi: 10.1016/s0003-4975(01)02746-1.